GlassScriptPhysician profile
Ronald A Bays
NPI 1073596037
$39,794.41
in general payments reported to CMS, 2019-2025
31 companies · $14K in 2025
The $14K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,176 · 2020: $525 · 2021: $451 · 2022: $947 · 2023: $9,783 · 2024: $11K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $26K · Food and Beverage: $5,212 · Travel and Lodging: $1,567 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $26,416.67 |
| Food and Beverage | $5,211.86 |
| Travel and Lodging | $1,567.45 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $26,499.81 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Endologix LLC | $4,683.77 | 2023-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| W. L. Gore & Associates, INC. | $2,619.14 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Abbott Laboratories | $1,747.46 | 2019-2025 | Diamondback Peripheral, Esprit, Supera |
| Cardiovascular Systems INC. | $862.78 | 2019-2023 | Diamondback Peripheral |
| Silk Road Medical, INC. | $744.06 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $494.08 | 2019-2024 | (Bh4) Igt Devices Undivided, (9520) Igt Devices Undivided, (6582) Visions 035 |
| Cardiva Medical, INC. | $374.76 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $313.26 | 2019-2023 | Varithena Administration Pack |
| Imperative Care, INC | $156.82 | 2025 | Prodigy Catheter, Symphony Catheter |
| Janssen Pharmaceuticals, INC | $152.86 | 2021-2024 | Xarelto |
| Medtronic Vascular, INC. | $140.11 | 2019-2020 | |
| Medtronic USA, INC. | $130.54 | 2019 | |
| Smith+Nephew, INC. | $128.44 | 2023 | Stravix, Collagenase Santyl, Grafix Pl |
| Terumo Medical Corporation | $106.56 | 2019-2025 | Glidewire, Azur Cx Detachable, Angio-Seal |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $95.75 | 2019-2024 | Venclose Maven Catheter |
| Cook Medical LLC | $94.74 | 2019-2025 | Zenith, Cook Celect, Icast Covered Stent System, 6mmx22mmx120cm |
| Cardinal Health 200 LLC | $72.24 | 2019 | |
| Teleflex LLC | $68.07 | 2021-2025 | Manta |
| Medtronic, INC. | $54.66 | 2021-2024 | Valiant Captivia |
| Bolton Medical INC | $46.70 | 2024 | Treo Abdominal Stent-Graft System |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $43.12 | 2019 | |
| Solventum Corporation | $28.72 | 2025 | Prevena |
| Stryker Corporation | $27.08 | 2020 | |
| Shockwave Medical, INC | $23.39 | 2022 | |
| Asahi Intecc USA, INC. | $18.69 | 2024 | Peripheral Vascular |
| Cordis US Corp. | $17.70 | 2025 | Mynx Control |
| Kci USA, INC. | $13.18 | 2023 | Prevena |
| Veryan Medical Incorporated | $12.46 | 2021 | |
| Getinge USA Sales, LLC | $12.34 | 2019 | |
| Pfizer INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Bays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.